🔥 Gate Square Event: #PostToWinNIGHT 🔥
Post anything related to NIGHT to join!
Market outlook, project thoughts, research takeaways, user experience — all count.
📅 Event Duration: Dec 10 08:00 - Dec 21 16:00 UTC
📌 How to Participate
1️⃣ Post on Gate Square (text, analysis, opinions, or image posts are all valid)
2️⃣ Add the hashtag #PostToWinNIGHT or #发帖赢代币NIGHT
🏆 Rewards (Total: 1,000 NIGHT)
🥇 Top 1: 200 NIGHT
🥈 Top 4: 100 NIGHT each
🥉 Top 10: 40 NIGHT each
📄 Notes
Content must be original (no plagiarism or repetitive spam)
Winners must complete Gate Square identity verification
Gat
YZi Labs announced today its investment in regenerative medicine company Renewal Bio.
Deep潮 TechFlow News, November 11th, YZi Labs announced today an investment in regenerative medicine company Renewal Bio. This is YZi Labs’ first biotech investment since expanding its investment scope in early 2025. Renewal Bio focuses on utilizing its proprietary Stembroid™ platform to generate human cells and tissues that are DNA-matched to patients from their own cells, aiming to address the global organ shortage crisis.
Over 150,000 organ transplants are performed worldwide each year, but less than 10% of the demand is met. Renewal Bio reprograms ordinary skin or blood cells into stem cells by simulating the early human developmental environment, producing various functional cells including hematopoietic, liver, heart, and pancreatic cells.
The company was co-founded in 2022 by Professor Jacob Hanna from the Weizmann Institute of Science and two PhD students in his laboratory, Vladislav Krupalnik and Ohad Gafni. This funding round will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells for leukemia and immune disease treatments, as well as support laboratory infrastructure expansion.